创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

谢院生. 中草药相关肾损害的影响因素与防治策略[J]. 药学进展, 2020, 44(10): 743-751.
引用本文: 谢院生. 中草药相关肾损害的影响因素与防治策略[J]. 药学进展, 2020, 44(10): 743-751.
XIE Yuansheng. Influence Factors and Prevention and Treatment Strategies of Chinese Herbal Medicine-related Renal Damage[J]. Progress in Pharmaceutical Sciences, 2020, 44(10): 743-751.
Citation: XIE Yuansheng. Influence Factors and Prevention and Treatment Strategies of Chinese Herbal Medicine-related Renal Damage[J]. Progress in Pharmaceutical Sciences, 2020, 44(10): 743-751.

中草药相关肾损害的影响因素与防治策略

Influence Factors and Prevention and Treatment Strategies of Chinese Herbal Medicine-related Renal Damage

  • 摘要: 中草药相关肾损害在临床上较常见,是肾小管间质损害、肾功能不全和慢性肾脏病急性加重的重要原因,但人们对其认识还很有限。以马兜铃酸肾病为例,介绍中草药相关肾损害常见的致病药物、肾损害的发生发展机制和影响因素、肾损害的诊治和预防,旨在提高人们对中草药相关肾损害的认识和重视程度,及时诊断并避免误诊误治,有效预防和减少中草药相关肾损害的发生和发展。

     

    Abstract: Chinese herbal medicine-related renal damage is very common in clinical practice and is an important cause of renal tubular interstitial damage, renal insufficiency and acute exacerbation of chronic kidney disease, yet our understanding of it still remains quite limited. Represented by aristolochic acid nephropathy, this paper introduces the common pathogenic drugs, development mechanism and influence factors, the diagnosis, treatment and prevention of the renal damage, aiming to improve our understanding of Chinese herbal medicine-related renal damage and the importance through timely diagnosis and correct control, and to effectively prevent and reduce the occurrence and development of Chinese herbal medicine-related renal damage.

     

/

返回文章
返回